Washington: Researchers have revealed that a clinical trial where cancer cells were targeted by modified version of the measles virus has shown positive early results.
The trial suggests that when the modified virus was given to patients with multiple myeloma, a rare cancer affecting white blood cells in bone marrow specifically they reduced the tumor, the Verge reported.
The researchers revealed that this is the first time, through an intravenous injection; they were able to eliminate cancer in a human subject using the virus. The modified virus was able to target the tumors itself and even treat affected bone marrow.
Dr. Stephen J. Russell, the study's lead author said that they believe this particular treatment approach can be the single shot cure.